Buys
Open market- Shares
- Avg price
- Total value
Donald Notman - Chief Operating Officer at OCULAR THERAPEUTIX, INC
Issuer-level insider activity
- Role
- Chief Operating Officer
- Issuer ticker
- OCUL on Nasdaq
- Entity type
- Individual
- Source filing history
- Open source filing history
Identity
Names, identifiers, and filing context for this profile.
1 identity field
Source evidence
Original filing metadata and source links for verification.
1 source field
Past-year transaction volume for Donald Notman in OCULAR THERAPEUTIX, INC
Sells
Open market- Shares
- -24,002
- Avg price
- $9.09
- Total value
- -$218,120
Net
Past year- Shares
- -24,002
- Share %
- -100%
- Total value
- -$218,120
Reported holdings for Donald Notman in OCULAR THERAPEUTIX, INC
Form 4 holding
Chief Operating Officer
OCULAR THERAPEUTIX, INC
- Security class
- Common Stock
- Shares / value
- 366,356
- Estimated value
- $3,311,858
- Report date
- 12 Feb 2026
- Price
- $9.04
- Ownership
- Direct
Form 4 holding
Chief Operating Officer
OCULAR THERAPEUTIX, INC
- Security class
- Stock Option (Right to Buy)
- Shares / value
- 240,932
- Estimated value
- Report date
- 02 Jan 2026
- Price
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
Transaction history for Donald Notman in OCULAR THERAPEUTIX, INC
| Sym | Class | Transaction | % | SEC-reported value | SEC-reported price | Shares | Shares after | Date | Ownership |
|---|
* marks a reported price that did not pass the local price check.